Multidrug resistant acinetobacter infection and their antimicrobial susceptibility pattern in a Nigerian tertiary hospital ICU

African Journal of Infectious Diseases

Volumn 8, Issue 1, 2014, Pages 14-18

  Nwadike, Victor Ugochukwul ^a   Ojide, Chiedozie Kingsley ^b   Kalu, Eziyi Iche ^a,c  

^a FEDERAL MEDICAL CENTER   (Nigeria)

^b UNIVERSITY OF UYO   (Nigeria)

^c UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Acinotebacter infection; Intensive care unit; Multidrug resistant

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFTRIAXONE; CIPROFLOXACIN; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; OFLOXACIN; SULTAMICILLIN;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER INFECTION; ACINETOBACTER LWOFFII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD CULTURE; CHILD; DRUG SENSITIVITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NIGERIA; PRESCHOOL CHILD; SCHOOL CHILD; TERTIARY HEALTH CARE; TRACHEAL ASPIRATION PROCEDURE; URINE CULTURE; WOUND;

EID: 84887453230     PISSN: 20060165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Aharon, A., Shiri, N. V., Orly, H. M., Tami, K., Yardena, S. I. and Ehuda, C. (2005). Multidrug-resistant Acinetobacter baumannii. Emerg. Infect. Dis. 11: 22-28.
2. Bergogne-Bérézin, E. (2001). The Increasing Role of Acinetobacter Spps As Nosocomial Pathogens. Curr Infect Dis Rep. 3(5):440-444.
3. Bonomo, R. A., and Szabo, D. (2006) Mechanisms of multidrug resistance in Acinetobacter spp and Pseudomonas aeruginosa. Clin Infect Dis; 43: 49-56.
4. Boon, H. K., Yasmin, A. H., Mohd, M. Y. and Kwai, L. T. (2011). Antimicrobial Susceptibility Profiling and Genomic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolates from a Teaching Hospital in Malaysia. Jpn. J. Infect. Dis. 64: 337-340.
5. Dhabaan, N. G., Hamimah, H. and Shorman, M. A. (2011). Emergence of extensive drug-resistant Acinetobacter baumannii in North of Jordan. Afr. J. Microbiol. Res. 5: 1070-1075.
6. Dijkshoorn, L., Nemec, A. and Seifert H. (2007). An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5: 939-954.
7. Ecker, J. A., Massire, C., Hall, T. A., Ranken, R., Pennella, T. T., Agasino, I. C. and Blyn, B. L. (2006). Identification of Acinetobacter spp and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry. J. Clin. Microbiol. 44: 2921-2932.
8. Falagas, M. E., Koletsi, P. K. and Bliziotis, I. A. (2006). The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol. 55:1619-29.
9. Federico, P., Hujer, A. M., Hujer, K. M., Brooke, K. D., Philip, N. R. and Bonomo, R. A. (2007). Global Challenge of Multidrug-Resistant Acinetobacter baumannii. Antimicrob. agents chemother. 51: 3471-3484.
10. Giamarellou, H., Antoniadou, A. and Kanellakopoulou, K. (2008). Acinetobacter baumannii: A universal threat to public health. Int. J. Antimicrob. Agents.32: 106-119.
11. Iregbu, K. C., Ogunsola, F. T. and Odugbemi, T. O. (2002). Infections caused by Acinetobacter spp and their susceptibility to 14 antibiotics in Lagos University Teaching Hospital, Lagos. West Afr. J. Med. 21: 226-229
12. Ji Jung, Moo Park, Song Kim, Byung Park, Ji Son, Eun Kim, Joo Lim, Sang Lee, Sang Lee, Kyung Lee, Young Kang, Se Kim, Joon Chang, Young Kim (2010). Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect. Dis. 10: 228-239.
13. Kessaris, A., Kravaritt, M., Postolopoulou, O., Bakola, D. and Sfiras, D. (2006). The incidence of infections caused by multi-drug resistant Acinetobacter baumannii. ICU. 19: 232-236.
14. Lul, R., Smilja, K., Zrinka, B., Ana, B., Stjepan, K., Dubravko, Š. and Gjyle Mulliqi, O. (2009). Molecular Epidemiology of Acinetobacter baumannii in Central Intensive Care Unit in Kosova Teaching Hospital. BJID. 13: 408-413.
15. Maragakis, L. L., and Perl, T. M. (2008). Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin. Infect. Dis. 46:1254-1263.
16. Oberoi, A., Aruna, A. and Madan, L. (2009). A Decade of an Underestimated Nosocomal Pathogen- Acinetobacter in a Tertiary Care Hospital in Punjab, JK Science. 11: 24-26.
17. Pachon-Ibanez, M. E., Jimenez-Mejias. M. E., Pichardo, C., Llanos, A. C., and Pachon, J. (2004) Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem. Antimicrob Agents Chemother. 48:4479-81.
18. Patwardhan, R. B., Dhakephalkar, P. K., Niphadkar, K. B. and Chopade, B. A. (2008). A study on nosocomial pathogens in ICU with special reference to multiresistant Acinetobacter baumannii harbouring multiple plasmids. Indian J. Med. Res. 128: 178-187.
19. Prashanth, K., and Badrinath S., (2006). Nosocomial infections due to Acinetobacter spp: clinical findings, risk and prognostic factors. Indian J. Med. Microbiol., 24 (1):39-44.
20. Seifert, H., Stefanik, D., and Wisplinghoff, H. (2006). Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates. J Antimicrob Chemother. 58:1099-100.
21. Shete, V., Ghadage, D., Muley, V. and Bhore, A. (2010). Multidrug resistant Acinetobacter ventilator associated pneumonia. Lung India. 4: 217-221.
22. Souli, M., Galaini, I., and Giamarellou, H. (2008). Emergence of extensively drug-resistant and pandrug resistant Gram negative bacilli in Europe. Eurosurveillance. 13: 1-10.
23. Wood, G. C., Hanes, S. D., Croce, M. A., Fabian, T. C., and Boucher, B. A. (2002). Comparison of ampicillin-sulbactam and imipenemcilastatin for the treatment of Acinetobacter ventilator-associated pneumonia. Clin Infect Dis. 34:1425-30.